Why a South-Facing Home Might Still Leave You Exhausted: The Science of Light Timing
"It faces south, so why am I still so tired?" It is a common frustration for people who move into a new home expecting the abundance of natural light...
Search results for "Bio"
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub
Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a Chinese biotechnology R&D and...
Osteoporosis Drugs That Can Be Hard to Keep Taking…Could ‘Sleeping Bone Cells’ Offer a Breakthrough?
Some patients need to rebuild bone quickly. These are people at high fracture risk—those who have already broken a bone...
New Biologic Drug Lands in Korea: Expanded Relief for Chronic Rhinosinusitis and Nasal Polyps
A biologic medication previously recognized for its effectiveness in treating severe asthma is now offering a new...
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour...
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...
Height and Health: Does Being Taller Increase Disease Risk for East Asians?
While many parents hope their children grow to be taller than average, new research suggests that significant height...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...